Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs
- PMID: 16378959
- PMCID: PMC1346856
- DOI: 10.1128/JVI.80.2.571-577.2006
Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs
Abstract
Short interfering RNAs (siRNAs) targeting viral or cellular genes can efficiently inhibit human immunodeficiency virus type 1 (HIV-1) replication. Nevertheless, the emergence of mutations in the gene being targeted could lead to the rapid escape from the siRNA. Here, we simulate viral escape by systematically introducing single-nucleotide substitutions in all 19 HIV-1 residues targeted by an effective siRNA. We found that all mutant viruses that were tested replicated better in the presence of the siRNA than in the presence of the wild-type virus. The antiviral activity of the siRNA was completely abolished by single substitutions in 10 (positions 4 to 11, 14, and 15) out of 16 positions tested (substitution at 3 of the 19 positions explored rendered nonviable viruses). With the exception of the substitution observed at position 12, substitutions at either the 5' end or the 3' end (positions 1 to 3, 16, and 18) were better tolerated by the RNA interference machinery and only in part affected siRNA inhibition. Our results show that optimal HIV-1 gene silencing by siRNA requires a complete homology within most of the target sequence and that substitutions at only a few positions at the 5' and 3' ends are partially tolerated.
Figures




Similar articles
-
Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.Virology. 2004 Dec 5;330(1):221-32. doi: 10.1016/j.virol.2004.09.027. Virology. 2004. PMID: 15527848
-
Inhibition of drug-resistant HIV-1 by RNA interference.Antiviral Res. 2006 Jan;69(1):1-8. doi: 10.1016/j.antiviral.2005.10.001. Epub 2005 Nov 2. Antiviral Res. 2006. PMID: 16290277
-
RNA interference as a tool for exploring HIV-1 robustness.J Mol Biol. 2011 Oct 14;413(1):84-96. doi: 10.1016/j.jmb.2011.08.035. Epub 2011 Aug 22. J Mol Biol. 2011. PMID: 21875599
-
[RNA interference and its application in inhibiting HIV-1 infection].Sheng Wu Gong Cheng Xue Bao. 2005 Jul;21(4):516-9. Sheng Wu Gong Cheng Xue Bao. 2005. PMID: 16176084 Review. Chinese.
-
siRNA, miRNA and HIV: promises and challenges.Cell Res. 2005 Nov-Dec;15(11-12):935-46. doi: 10.1038/sj.cr.7290371. Cell Res. 2005. PMID: 16354572 Review.
Cited by
-
Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success.Virol J. 2009 Oct 30;6:184. doi: 10.1186/1743-422X-6-184. Virol J. 2009. PMID: 19878571 Free PMC article.
-
The potential of RNA interference-based therapies for viral infections.Curr HIV/AIDS Rep. 2008 Feb;5(1):33-9. doi: 10.1007/s11904-008-0006-4. Curr HIV/AIDS Rep. 2008. PMID: 18417033 Free PMC article. Review.
-
Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.Evol Bioinform Online. 2013 May 16;9:203-13. doi: 10.4137/EBO.S11412. Print 2013. Evol Bioinform Online. 2013. PMID: 23761954 Free PMC article.
-
Engineering T Cells to Functionally Cure HIV-1 Infection.Mol Ther. 2015 Jul;23(7):1149-1159. doi: 10.1038/mt.2015.70. Epub 2015 Apr 21. Mol Ther. 2015. PMID: 25896251 Free PMC article. Review.
-
Emergence of a complex relationship between HIV-1 and the microRNA pathway.Methods Mol Biol. 2009;487:415-33. doi: 10.1007/978-1-60327-547-7_20. Methods Mol Biol. 2009. PMID: 19301659 Free PMC article. Review.
References
-
- Bennasser, Y., S. Y. Le, M. Benkirane, and K. T. Jeang. 2005. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22:607-619. - PubMed
-
- Bernstein, E., A. A. Caudy, S. M. Hammond, and G. J. Hannon. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366. - PubMed
-
- Boucher, C. A. B., W. Keulen, T. van Bommel, M. Nijhuis, D. de Jong, M. D. de Jong, P. Schipper, and N. K. T. Back. 1996. Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay. Antimicrob. Agents Chemother. 40:2404-2409. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources